MolPharm Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on May 4, 2005; DOI: 10.1124/mol.105.012765


0026-895X/05/6802-286-297$20.00
Mol Pharmacol 68:286-297, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.012765v1
68/2/286    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leung, C.-H.
Right arrow Articles by Cheng, Y.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leung, C.-H.
Right arrow Articles by Cheng, Y.-C.

Novel Mechanism of Inhibition of Nuclear Factor-{kappa}B DNA-Binding Activity by Diterpenoids Isolated from Isodon rubescens

Chung-Hang Leung, Susan P. Grill, Wing Lam, Quan-Bin Han, Han-Dong Sun, and Yung-Chi Cheng

Department of Pharmacology, School of Medicine, Yale University, New Haven, Connecticut (C.-H.L., S.P.G., W.L., Y.-C.C.); and State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, People's Republic of China (Q.-B.H., H.-D.S.)

The development of specific inhibitors that can block nuclear factor-{kappa}B (NF-{kappa}B) activation is an approach for the treatment of cancer, autoimmune, and inflammatory diseases. Several diterpenoids, oridonin, ponicidin, xindongnin A, and xindongnin B were isolated from the herb Isodon rubescens. These compounds were found to be potent inhibitors of NF-{kappa}B transcription activity and the expression of its downstream targets, cyclooxygenase-2 and inducible nitric-oxide synthase. The mechanisms of action of the diterpenoids against NF-{kappa}B are similar, but significant differences were also identified. All of the diterpenoids directly interfere with the DNA-binding activity of NF-{kappa}B to its response DNA sequence. Oridonin and ponicidin have an additional impact on the translocation of NF-{kappa}B from the cytoplasm to nuclei without affecting I{kappa}B-{alpha} phosphorylation and degradation. The effect of these compounds on the interaction of NF-{kappa}B with consensus DNA sequences is unique. Different inhibitory effects were observed when NF-{kappa}B bound to various DNA sequences. Both p65/p65 and p50/p50 homodimers, as well as p65/p50 heterodimer association with their responsive DNA, were inhibited. Kinetic studies on NF-{kappa}B-DNA interaction indicate that the diterpenoids decrease the Bmax app but have no effect on Kd app. This suggests that this class of compounds interacts with both p65 and p50 subunits at a site other than the DNA binding site and subsequently modulates the binding affinity of the transcription factor toward DNA with different NF-{kappa}B binding sequences. The diterpenoid structure could therefore serve as a scaffold for the development of more potent and selective NF-{kappa}B inhibitors that target regulated gene transcription.


Received March 11, 2005; accepted May 3, 2005

Address correspondence to: Dr. Yung-Chi Cheng, Department of Pharmacology, School of Medicine, Yale University, 333 Cedar Street, New Haven, CT 06520-8066. E-mail: YCCheng{at}Yale.edu




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
A. Moussaieff, E. Shohami, Y. Kashman, E. Fride, M. L. Schmitz, F. Renner, B. L. Fiebich, E. Munoz, Y. Ben-Neriah, and R. Mechoulam
Incensole Acetate, a Novel Anti-Inflammatory Compound Isolated from Boswellia Resin, Inhibits Nuclear Factor-{kappa}B Activation
Mol. Pharmacol., December 1, 2007; 72(6): 1657 - 1664.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G.-B. Zhou, H. Kang, L. Wang, L. Gao, P. Liu, J. Xie, F.-X. Zhang, X.-Q. Weng, Z.-X. Shen, J. Chen, et al.
Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo
Blood, April 15, 2007; 109(8): 3441 - 3450.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C.-H. Leung, S. P. Grill, W. Lam, W. Gao, H.-D. Sun, and Y.-C. Cheng
Eriocalyxin B Inhibits Nuclear Factor-{kappa}B Activation by Interfering with the Binding of Both p65 and p50 to the Response Element in a Noncompetitive Manner
Mol. Pharmacol., December 1, 2006; 70(6): 1946 - 1955.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Yang, D. Chen, Q. C. Cui, X. Yuan, and Q. P. Dou
Celastrol, a Triterpene Extracted from the Chinese "Thunder of God Vine," Is a Potent Proteasome Inhibitor and Suppresses Human Prostate Cancer Growth in Nude Mice.
Cancer Res., May 1, 2006; 66(9): 4758 - 4765.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics